KennethR.MeehanMD

Oncology • Lebanon, NH

Professor of Medicine, Dartmouth Medical School

Join to view full profile

Dr. Meehan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Meehan's full profile

Already have an account?

Office
1 Medical Center Dr
Lebanon, NH 03756
Phone+1 603-650-4628

Fax+1 603-650-2334

Education & Training

Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 1989 - 1993
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1986 - 1989
Georgetown University School of MedicineClass of 1986

Certifications & Licensure

NH State Medical License 1992 - 2026
DC State Medical License 1994 - 2002
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Clinical Trials

Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma Start of enrollment: 2007 Jan 01
Completed
Phase 2
Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies Start of enrollment: 2004 Jun 01
Completed
Not Applicable
Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF Start of enrollment: 2003 Jan 01
Completed
Phase 1
Protocol to Obtain Blood and Bone Marrow Samples for Myeloma Research Start of enrollment: 2010 Aug 01
Terminated
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile Start of enrollment: 2011 Jul 01
Completed
Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy Start of enrollment: 2013 Dec 01
Completed
Phase 2
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression Start of enrollment: 2018 Mar 28
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Porcine-human glioma xenograft model. Immunosuppression and model reproducibility.
P Jack Hoopes, Armin D Tavakkoli, Karen A Moodie, Kirk J Maurer, Kenneth R Meehan
Cancer Treatment and Research Communications. 2024-01-01
1 citations
Should Thiotepa-Based Regimens Be the New Transplant Conditioning Strategy for Primary Central Nervous System Lymphoma?
John M. Hill, Kenneth R. Meehan
JAMA Oncology. 2021-07-01
Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era.
Binod Dhakal, Sagar Patel, Saulius Girnius, Lohith Bachegowda, Raphael Fraser
Leukemia. 2021-07-01

Grant Support

NK Cell Activating Receptors On Effector Cells In Myeloma Patients Receiving TraNational Center For Research Resources2009–2010
Mechanisms Of Coagulation Activation In CancerNational Cancer Institute1991–1993

Professional Memberships

American Society of Clinical Oncology - ASCO
Member